UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034254
Receipt number R000038795
Scientific Title Japan Society of Obstetrics and Gynecology Gynecologic Tumor Committee: Survey on Fertility-Sparing Treatment for Early stage Endometrial Cancer in Japan
Date of disclosure of the study information 2018/09/26
Last modified on 2023/04/02 14:24:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japan Society of Obstetrics and Gynecology Gynecologic Tumor Committee: Survey on Fertility-Sparing Treatment for Early stage Endometrial Cancer in Japan

Acronym

Survey on Fertility-Sparing Treatment for Endometrial Cancer

Scientific Title

Japan Society of Obstetrics and Gynecology Gynecologic Tumor Committee: Survey on Fertility-Sparing Treatment for Early stage Endometrial Cancer in Japan

Scientific Title:Acronym

Survey on Fertility-Sparing Treatment for Endometrial Cancer

Region

Japan


Condition

Condition

Endometrial cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Recognize the current situation of fertility-sparing treatment for endometrial cancer, and propose the safe and effective treatment strategy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

National data of complete response rate of the end of fertility-sparing treatment

Key secondary outcomes

Frequency and grade of adverse event of the treatment, number of pregnancy and obstetrical prognosis after treatment


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Endometrial cancer patients who received fertility - sparing treated by the Japanese hospitals joining to the JSOG tumor committee and agreed to join this study.

Key exclusion criteria

Patients who has no indication of fertility sparing treatment. Patients who were already treated by the other hospitals.

Target sample size

270


Research contact person

Name of lead principal investigator

1st name Kimio
Middle name
Last name Ushijima

Organization

Kurume University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code

830-0011

Address

67 Asahi - machi Kurume

TEL

0942317573

Email

kimi@med.kurume-u.ac.jp


Public contact

Name of contact person

1st name Kimio
Middle name
Last name Ushijima

Organization

Kurume University School of Medicine Department of Obstetrics and Gynecology

Division name

Department of Obstetrics and Gynecology

Zip code

830-0011

Address

67 Asahi - machi Kurume

TEL

0942317573

Homepage URL


Email

kimi@med.kurume-u.ac.jp


Sponsor or person

Institute

Japan Society of Obstetrics & Gynecology, Gynecologic Tumor Committee

Institute

Department

Personal name



Funding Source

Organization

Japan Society of Obstetrics & Gynecology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kurume University Hospital Clinical Research Center

Address

67 Asahi machi, Kurume

Tel

0942-65-3749

Email

i_rinri@kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本産科婦人科学会婦人科腫瘍登録施設


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 26 Day


Related information

URL releasing protocol

http://www.jsog.or.jp/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 06 Month 21 Day

Date of IRB

2018 Year 08 Month 06 Day

Anticipated trial start date

2018 Year 08 Month 27 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry

2020 Year 10 Month 31 Day

Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2020 Year 12 Month 31 Day


Other

Other related information

not decided


Management information

Registered date

2018 Year 09 Month 25 Day

Last modified on

2023 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038795


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name